Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hau

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
Frontiers in Oncology|April 2, 2025
Editorial: Integrating health-related quality of life in neuro-oncologyMaria Teresa Pedro, Martina Messing-Jünger, Christine Jungk, et al.
Journal of Neurology|February 26, 2009
Rechallenge with temozolomide in patients with recurrent gliomasAntje Wick, Christina Pascher, Wolfgang Wick, et al.
Scientific Reports|February 16, 2019
Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasionMaria Alieva, Verena Leidgens, Markus J Riemenschneider, et al.
Journal of Neuropathology and Experimental Neurology|April 19, 2021
Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic SubgroupsTobias Goschzik, Anja Zur Muehlen, Evelyn Doerner, et al.
The Lancet. Neurology|August 14, 2010
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomasFrederic G Dhermain, Peter Hau, Heinrich Lanfermann, et al.
Oncotarget|August 25, 2016
Molecular dissection of the valproic acid effects on glioma cellsSabine Hoja, Markus Schulze, Michael Rehli, et al.
International Journal of Cancer|April 14, 2019
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysisCorinna Seliger, Els Genbrugge, Thierry Gorlia, et al.
Trends in Biotechnology|February 7, 2013
Stem cell metabolic and spectroscopic profilingPaul Ramm Sander, Peter Hau, Steffen Koch, et al.
Oncology|January 17, 2008
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case seriesMartin Glas, Horst Koch, Birgit Hirschmann, et al.
Journal of Neuro-Oncology|May 1, 2012
Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell linesDagmar Beier, Beate Schriefer, Konstantin Brawanski, et al.
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Frontiers in Oncology|April 2, 2025
Editorial: Integrating health-related quality of life in neuro-oncologyMaria Teresa Pedro, Martina Messing-Jünger, Christine Jungk, et al.
Journal of Neurology|February 26, 2009
Rechallenge with temozolomide in patients with recurrent gliomasAntje Wick, Christina Pascher, Wolfgang Wick, et al.
Scientific Reports|February 16, 2019
Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasionMaria Alieva, Verena Leidgens, Markus J Riemenschneider, et al.
Journal of Neuropathology and Experimental Neurology|April 19, 2021
Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic SubgroupsTobias Goschzik, Anja Zur Muehlen, Evelyn Doerner, et al.
The Lancet. Neurology|August 14, 2010
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomasFrederic G Dhermain, Peter Hau, Heinrich Lanfermann, et al.
Oncotarget|August 25, 2016
Molecular dissection of the valproic acid effects on glioma cellsSabine Hoja, Markus Schulze, Michael Rehli, et al.
International Journal of Cancer|April 14, 2019
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysisCorinna Seliger, Els Genbrugge, Thierry Gorlia, et al.
Trends in Biotechnology|February 7, 2013
Stem cell metabolic and spectroscopic profilingPaul Ramm Sander, Peter Hau, Steffen Koch, et al.
Oncology|January 17, 2008
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case seriesMartin Glas, Horst Koch, Birgit Hirschmann, et al.
Journal of Neuro-Oncology|May 1, 2012
Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell linesDagmar Beier, Beate Schriefer, Konstantin Brawanski, et al.
Pageof 18